BioCanRx Consultation Survey for Cancer Immunotherapy Research Priorities

The following message is from BioCanRx. “As some of you are aware, BioCanRx – Canada’s Immunotherapy Network, was awarded funding through the Government of Canada’s Strategic Science Fund for the period of 2024-2029. BioCanRx is a network of scientists, highly qualified personnel, clinicians, cancer stakeholders, NGOs and industry partners working together to accelerate the development of innovative cancer immunotherapy therapeutics. Since 2015, BioCanRx has taken

CADTH calls for Abstract for 2024 Symposium

The following is from Canada’s Drug and Health Technology Agency. “We are accepting abstracts for workshops, panels, early morning sessions, oral presentations, and posters for the 2024 CADTH Symposium, to be held from Wednesday, September 4 to Friday, September 6, 2024. The 2024 Symposium is a 3-day hybrid event providing in-person and virtual attendance options. The in-person program will take place at the Shaw Centre

Stress and Cancer: A Complex Relationship

International Stress Awareness Day falls at the beginning  of November,  and it highlighted a common question that we  often receive at the Canadian Cancer Survivor Network (CCSN). Even before the pandemic, stress levels were on the rise across the country. In 2022, Statistics Canada published information on the reported levels of stress for Canadians aged 12 and up. Respondents were asked if most days in

Two Wins for Cancer Screening in Canada

Cancer Can’t Wait, and two provincial governments in Canada have taken steps to implement early screening. In late October, Ontario Deputy Premier and Health Minister Sylvia Jones announced that starting in fall 2024,  women will be able to self-refer for a mammogram every two years, and regular breast cancer screenings will begin at age 40. This screening program is open to women, non-binary, trans, and

Cancer Can’t Wait: Disruption to Cancer Care Still Ongoing Nearly Three Years into Pandemic

The COVID-19 Pandemic will turn 3 this year, and during that time, cancer has not waited. Cancer care has still been disrupted, and tackling the backlog of surgeries and appointments has been slow in Canada. Our reports have found that cancer patients, survivors and caregivers have felt thrown under the bus through delays in their cancer care. We have also found that for these people,

Jackie Manthorne Atlantic CTV News Interview

Jackie Manthorne, president & CEO of the Canadian Cancer Survivor Network (CCSN), was interviewed on August 7, 2022 by Atlantic CTV News anchor Bruce Frisko about the results of the fourth CCSN survey in a series conducted by Leger to determine how cancer patients and caregivers from coast-to-coast are coping with the pandemic as it enters its third year, and how they are dealing with